 | • レポートコード：MRC2-11QY07465 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はMAPキナーゼ相互作用セリンプロテインキナーゼ1のグローバル市場について調査・分析したレポートです。種類別（セルコスポラミド、eFT-508、ETC-027、ETC-17804452、その他）市場規模、用途別（遺伝性疾患、脆弱X症候群、リンパ腫、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別MAPキナーゼ相互作用セリンプロテインキナーゼ1の競争状況、市場シェア ・世界のMAPキナーゼ相互作用セリンプロテインキナーゼ1市場：種類別市場規模 2015年-2020年（セルコスポラミド、eFT-508、ETC-027、ETC-17804452、その他） ・世界のMAPキナーゼ相互作用セリンプロテインキナーゼ1市場：種類別市場規模予測 2021年-2026年（セルコスポラミド、eFT-508、ETC-027、ETC-17804452、その他） ・世界のMAPキナーゼ相互作用セリンプロテインキナーゼ1市場：用途別市場規模 2015年-2020年（遺伝性疾患、脆弱X症候群、リンパ腫、その他） ・世界のMAPキナーゼ相互作用セリンプロテインキナーゼ1市場：用途別市場規模予測 2021年-2026年（遺伝性疾患、脆弱X症候群、リンパ腫、その他） ・北米のMAPキナーゼ相互作用セリンプロテインキナーゼ1市場分析：米国、カナダ ・ヨーロッパのMAPキナーゼ相互作用セリンプロテインキナーゼ1市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのMAPキナーゼ相互作用セリンプロテインキナーゼ1市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のMAPキナーゼ相互作用セリンプロテインキナーゼ1市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのMAPキナーゼ相互作用セリンプロテインキナーゼ1市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：eFFECTOR Therapeutics Inc、Eli Lilly and Company、Oncodesign SA ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global MAP Kinase Interacting Serine Protein Kinase 1 Market
The global MAP Kinase Interacting Serine Protein Kinase 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global MAP Kinase Interacting Serine Protein Kinase 1 Scope and Market Size
MAP Kinase Interacting Serine Protein Kinase 1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global MAP Kinase Interacting Serine Protein Kinase 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the MAP Kinase Interacting Serine Protein Kinase 1 market is segmented into
Cercosporamide
eFT-508
ETC-027
ETC-17804452
Others
Segment by Application, the MAP Kinase Interacting Serine Protein Kinase 1 market is segmented into
Genetic Disorders
Fragile X Sydrome
Lymphoma
Others
Regional and Country-level Analysis
The MAP Kinase Interacting Serine Protein Kinase 1 market is analysed and market size information is provided by regions (countries).
The key regions covered in the MAP Kinase Interacting Serine Protein Kinase 1 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and MAP Kinase Interacting Serine Protein Kinase 1 Market Share Analysis
MAP Kinase Interacting Serine Protein Kinase 1 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in MAP Kinase Interacting Serine Protein Kinase 1 business, the date to enter into the MAP Kinase Interacting Serine Protein Kinase 1 market, MAP Kinase Interacting Serine Protein Kinase 1 product introduction, recent developments, etc.
The major vendors covered:
eFFECTOR Therapeutics Inc
Eli Lilly and Company
Oncodesign SA
…
1 Study Coverage
1.1 MAP Kinase Interacting Serine Protein Kinase 1 Product Introduction
1.2 Market Segments
1.3 Key MAP Kinase Interacting Serine Protein Kinase 1 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size Growth Rate by Type
1.4.2 Cercosporamide
1.4.3 eFT-508
1.4.4 ETC-027
1.4.5 ETC-17804452
1.4.6 Others
1.5 Market by Application
1.5.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size Growth Rate by Application
1.5.2 Genetic Disorders
1.5.3 Fragile X Sydrome
1.5.4 Lymphoma
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size, Estimates and Forecasts
2.1.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue 2015-2026
2.1.2 Global MAP Kinase Interacting Serine Protein Kinase 1 Sales 2015-2026
2.2 Global MAP Kinase Interacting Serine Protein Kinase 1, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global MAP Kinase Interacting Serine Protein Kinase 1 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global MAP Kinase Interacting Serine Protein Kinase 1 Competitor Landscape by Players
3.1 MAP Kinase Interacting Serine Protein Kinase 1 Sales by Manufacturers
3.1.1 MAP Kinase Interacting Serine Protein Kinase 1 Sales by Manufacturers (2015-2020)
3.1.2 MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Manufacturers (2015-2020)
3.2 MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Manufacturers
3.2.1 MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Manufacturers (2015-2020)
3.2.2 MAP Kinase Interacting Serine Protein Kinase 1 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global MAP Kinase Interacting Serine Protein Kinase 1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by MAP Kinase Interacting Serine Protein Kinase 1 Revenue in 2019
3.2.5 Global MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 MAP Kinase Interacting Serine Protein Kinase 1 Price by Manufacturers
3.4 MAP Kinase Interacting Serine Protein Kinase 1 Manufacturing Base Distribution, Product Types
3.4.1 MAP Kinase Interacting Serine Protein Kinase 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers MAP Kinase Interacting Serine Protein Kinase 1 Product Type
3.4.3 Date of International Manufacturers Enter into MAP Kinase Interacting Serine Protein Kinase 1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size by Type (2015-2020)
4.1.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Sales by Type (2015-2020)
4.1.2 Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Type (2015-2020)
4.1.3 MAP Kinase Interacting Serine Protein Kinase 1 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast by Type (2021-2026)
4.2.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast by Type (2021-2026)
4.2.2 Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast by Type (2021-2026)
4.2.3 MAP Kinase Interacting Serine Protein Kinase 1 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size by Application (2015-2020)
5.1.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Sales by Application (2015-2020)
5.1.2 Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Application (2015-2020)
5.1.3 MAP Kinase Interacting Serine Protein Kinase 1 Price by Application (2015-2020)
5.2 MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast by Application (2021-2026)
5.2.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast by Application (2021-2026)
5.2.2 Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast by Application (2021-2026)
5.2.3 Global MAP Kinase Interacting Serine Protein Kinase 1 Price Forecast by Application (2021-2026)
6 North America
6.1 North America MAP Kinase Interacting Serine Protein Kinase 1 by Country
6.1.1 North America MAP Kinase Interacting Serine Protein Kinase 1 Sales by Country
6.1.2 North America MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America MAP Kinase Interacting Serine Protein Kinase 1 Market Facts & Figures by Type
6.3 North America MAP Kinase Interacting Serine Protein Kinase 1 Market Facts & Figures by Application
7 Europe
7.1 Europe MAP Kinase Interacting Serine Protein Kinase 1 by Country
7.1.1 Europe MAP Kinase Interacting Serine Protein Kinase 1 Sales by Country
7.1.2 Europe MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe MAP Kinase Interacting Serine Protein Kinase 1 Market Facts & Figures by Type
7.3 Europe MAP Kinase Interacting Serine Protein Kinase 1 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 by Region
8.1.1 Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Sales by Region
8.1.2 Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Market Facts & Figures by Type
8.3 Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Market Facts & Figures by Application
9 Latin America
9.1 Latin America MAP Kinase Interacting Serine Protein Kinase 1 by Country
9.1.1 Latin America MAP Kinase Interacting Serine Protein Kinase 1 Sales by Country
9.1.2 Latin America MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America MAP Kinase Interacting Serine Protein Kinase 1 Market Facts & Figures by Type
9.3 Central & South America MAP Kinase Interacting Serine Protein Kinase 1 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 by Country
10.1.1 Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Sales by Country
10.1.2 Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Market Facts & Figures by Type
10.3 Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Market Facts & Figures by Application
11 Company Profiles
11.1 eFFECTOR Therapeutics Inc
11.1.1 eFFECTOR Therapeutics Inc Corporation Information
11.1.2 eFFECTOR Therapeutics Inc Description and Business Overview
11.1.3 eFFECTOR Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 eFFECTOR Therapeutics Inc MAP Kinase Interacting Serine Protein Kinase 1 Products Offered
11.1.5 eFFECTOR Therapeutics Inc Related Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Corporation Information
11.2.2 Eli Lilly and Company Description and Business Overview
11.2.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly and Company MAP Kinase Interacting Serine Protein Kinase 1 Products Offered
11.2.5 Eli Lilly and Company Related Developments
11.3 Oncodesign SA
11.3.1 Oncodesign SA Corporation Information
11.3.2 Oncodesign SA Description and Business Overview
11.3.3 Oncodesign SA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Oncodesign SA MAP Kinase Interacting Serine Protein Kinase 1 Products Offered
11.3.5 Oncodesign SA Related Developments
11.1 eFFECTOR Therapeutics Inc
11.1.1 eFFECTOR Therapeutics Inc Corporation Information
11.1.2 eFFECTOR Therapeutics Inc Description and Business Overview
11.1.3 eFFECTOR Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 eFFECTOR Therapeutics Inc MAP Kinase Interacting Serine Protein Kinase 1 Products Offered
11.1.5 eFFECTOR Therapeutics Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 MAP Kinase Interacting Serine Protein Kinase 1 Market Estimates and Projections by Region
12.1.1 Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast by Regions 2021-2026
12.1.2 Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast by Regions 2021-2026
12.2 North America MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast (2021-2026)
12.2.1 North America: MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast (2021-2026)
12.2.2 North America: MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast (2021-2026)
12.2.3 North America: MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast by Country (2021-2026)
12.3 Europe MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast (2021-2026)
12.3.1 Europe: MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast (2021-2026)
12.3.2 Europe: MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast (2021-2026)
12.3.3 Europe: MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast by Region (2021-2026)
12.5 Latin America MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast (2021-2026)
12.5.1 Latin America: MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast (2021-2026)
12.5.2 Latin America: MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast (2021-2026)
12.5.3 Latin America: MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: MAP Kinase Interacting Serine Protein Kinase 1 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key MAP Kinase Interacting Serine Protein Kinase 1 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 MAP Kinase Interacting Serine Protein Kinase 1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. MAP Kinase Interacting Serine Protein Kinase 1 Market Segments
Table 2. Ranking of Global Top MAP Kinase Interacting Serine Protein Kinase 1 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Cercosporamide
Table 5. Major Manufacturers of eFT-508
Table 6. Major Manufacturers of ETC-027
Table 7. Major Manufacturers of ETC-17804452
Table 8. Major Manufacturers of Others
Table 9. Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Regions (2015-2020)
Table 13. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Share by Manufacturers (2015-2020)
Table 16. Global MAP Kinase Interacting Serine Protein Kinase 1 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global MAP Kinase Interacting Serine Protein Kinase 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MAP Kinase Interacting Serine Protein Kinase 1 as of 2019)
Table 18. MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. MAP Kinase Interacting Serine Protein Kinase 1 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers MAP Kinase Interacting Serine Protein Kinase 1 Price (2015-2020) (USD/Pcs)
Table 21. MAP Kinase Interacting Serine Protein Kinase 1 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers MAP Kinase Interacting Serine Protein Kinase 1 Product Type
Table 23. Date of International Manufacturers Enter into MAP Kinase Interacting Serine Protein Kinase 1 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 26. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Share by Type (2015-2020)
Table 27. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Share by Type (2015-2020)
Table 29. MAP Kinase Interacting Serine Protein Kinase 1 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 31. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Share by Application (2015-2020)
Table 32. North America MAP Kinase Interacting Serine Protein Kinase 1 Sales by Country (2015-2020) (K Pcs)
Table 33. North America MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Country (2015-2020)
Table 34. North America MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Country (2015-2020)
Table 36. North America MAP Kinase Interacting Serine Protein Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 37. North America MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Type (2015-2020)
Table 38. North America MAP Kinase Interacting Serine Protein Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 39. North America MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Application (2015-2020)
Table 40. Europe MAP Kinase Interacting Serine Protein Kinase 1 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Country (2015-2020)
Table 42. Europe MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Country (2015-2020)
Table 44. Europe MAP Kinase Interacting Serine Protein Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Type (2015-2020)
Table 46. Europe MAP Kinase Interacting Serine Protein Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Application (2015-2020)
Table 56. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Country (2015-2020)
Table 60. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Type (2015-2020)
Table 62. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Application (2015-2020)
Table 72. eFFECTOR Therapeutics Inc Corporation Information
Table 73. eFFECTOR Therapeutics Inc Description and Major Businesses
Table 74. eFFECTOR Therapeutics Inc MAP Kinase Interacting Serine Protein Kinase 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. eFFECTOR Therapeutics Inc Product
Table 76. eFFECTOR Therapeutics Inc Recent Development
Table 77. Eli Lilly and Company Corporation Information
Table 78. Eli Lilly and Company Description and Major Businesses
Table 79. Eli Lilly and Company MAP Kinase Interacting Serine Protein Kinase 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Eli Lilly and Company Product
Table 81. Eli Lilly and Company Recent Development
Table 82. Oncodesign SA Corporation Information
Table 83. Oncodesign SA Description and Major Businesses
Table 84. Oncodesign SA MAP Kinase Interacting Serine Protein Kinase 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Oncodesign SA Product
Table 86. Oncodesign SA Recent Development
Table 87. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 88. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share Forecast by Regions (2021-2026)
Table 89. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 90. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share Forecast by Regions (2021-2026)
Table 91. North America: MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. North America: MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Europe: MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 94. Europe: MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Asia Pacific: MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast by Region (2021-2026) (K Pcs)
Table 96. Asia Pacific: MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 97. Latin America: MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 98. Latin America: MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Middle East and Africa: MAP Kinase Interacting Serine Protein Kinase 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 100. Middle East and Africa: MAP Kinase Interacting Serine Protein Kinase 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 102. Key Challenges
Table 103. Market Risks
Table 104. Main Points Interviewed from Key MAP Kinase Interacting Serine Protein Kinase 1 Players
Table 105. MAP Kinase Interacting Serine Protein Kinase 1 Customers List
Table 106. MAP Kinase Interacting Serine Protein Kinase 1 Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. MAP Kinase Interacting Serine Protein Kinase 1 Product Picture
Figure 2. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Type in 2020 & 2026
Figure 3. Cercosporamide Product Picture
Figure 4. eFT-508 Product Picture
Figure 5. ETC-027 Product Picture
Figure 6. ETC-17804452 Product Picture
Figure 7. Others Product Picture
Figure 8. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Application in 2020 & 2026
Figure 9. Genetic Disorders
Figure 10. Fragile X Sydrome
Figure 11. Lymphoma
Figure 12. Others
Figure 13. MAP Kinase Interacting Serine Protein Kinase 1 Report Years Considered
Figure 14. Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size 2015-2026 (US$ Million)
Figure 15. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales 2015-2026 (K Pcs)
Figure 16. Global MAP Kinase Interacting Serine Protein Kinase 1 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Region (2015-2020)
Figure 18. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Region in 2019
Figure 19. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Region (2015-2020)
Figure 20. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Region in 2019
Figure 21. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by MAP Kinase Interacting Serine Protein Kinase 1 Revenue in 2019
Figure 23. MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Type (2015-2020)
Figure 25. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Type in 2019
Figure 26. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Type (2015-2020)
Figure 27. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Type in 2019
Figure 28. Global MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Price Range (2015-2020)
Figure 29. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Application (2015-2020)
Figure 30. Global MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Application in 2019
Figure 31. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Application (2015-2020)
Figure 32. Global MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Application in 2019
Figure 33. North America MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Country in 2019
Figure 36. North America MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Country in 2019
Figure 37. U.S. MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Type in 2019
Figure 42. North America MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Application in 2019
Figure 43. Europe MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Country in 2019
Figure 46. Europe MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Country in 2019
Figure 47. Germany MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Type in 2019
Figure 58. Europe MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Application in 2019
Figure 59. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Region in 2019
Figure 62. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Region in 2019
Figure 63. China MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Type in 2019
Figure 86. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Application in 2019
Figure 87. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Country in 2019
Figure 90. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Country in 2019
Figure 91. Mexico MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Type in 2019
Figure 98. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Application in 2019
Figure 99. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Revenue Market Share by Country in 2019
Figure 103. Turkey MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Type in 2019
Figure 110. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Market Share by Application in 2019
Figure 111. North America MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa MAP Kinase Interacting Serine Protein Kinase 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
セリンプロテインキナーゼの世界市場（～2026年） Market Analysis and Insights: Global Serine Protein Kinase Market The global Serine Protein Kinase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Serine Protein Kinase Scope and Market Size Serine Protein Kinase marke…- RACガンマセリン/スレオニンプロテインキナーゼの世界市場（～2026年） Market Analysis and Insights: Global RAC Gamma Serine/Threonine Protein Kinase Market The global RAC Gamma Serine/Threonine Protein Kinase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global RAC Gamma Serine/Threonine Prot…
- RACベータセリン/スレオニンプロテインキナーゼの世界市場（～2026年） Market Analysis and Insights: Global RAC Beta Serine/Threonine Protein Kinase Market The global RAC Beta Serine/Threonine Protein Kinase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global RAC Beta Serine/Threonine Protein…
- RAFプロトオンコジーンセリン/スレオニンプロテインキナーゼの世界市場（～2026年） Market Analysis and Insights: Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market The global RAF Proto Oncogene Serine/Threonine Protein Kinase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global RAF Proto Onc…
- プロテインキナーゼCイプシロンタイプの世界市場（～2026年） Market Analysis and Insights: Global Protein Kinase C Epsilon Type Market The global Protein Kinase C Epsilon Type market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Protein Kinase C Epsilon Type Scope and Market Size Pro…